News & Events


  • 21 Sep. 2022 / 3:00 pm
    Pahama Hall, Hadasssah Ein Kerem, Jerusalem

    Hadasit conference: “Money talks! Early stage funding in the biomed sector

    Early Stage Funding in the BioMed Sector

    If you are:

    A physician/researcher thinking about taking your idea to the next stage
    Early-stage biomedical company
    Entrepreneur looking for your next adventure

    Hadasit is inviting you to join us at our semi – annual conference to hear about current funding opportunities for the early-stage projects in the bio and medtech sector.

    15:00 – 15:30 – Networking and refreshments
    15:30 – 15:40 – Opening Remarks – Dr. Tamar Raz, Hadasit CEO
    15:40 – 16:00 – Joint research and infrastructures that can boost your investments with low spending – Dr. Aviv Zeevi Balasiano, VP, Israel Innovation Authority
    16:00 – 16:20 – The Incubator path – pros and cons. Real life examples from MindUP – Dan Shwarzman, CEO, MindUP incubator
    16:20 – 16:40 – Non-dilutive grants, to fund your R&D activities – Dr. Sigal Yosef, Head of Life Science Innovation and R&D Incentives Center, EY
    16:40 – 17:00 – From BioTech to TechBio – Omri Amirav-Drory, General Partner, NFX Capital
    17:00 – 17:30 – Panel session: QA from the real world – ask your hard questions, get your real answers
    17:30 – 18:00 – Closing, desserts and networking

    Where: The event shall take place physically at the Panama Hall of Hadassah Ein Kerem campus, Jerusalem.

    Registration link:

    For any questions please contact Mrs. Masha Zavin:, +972504048827

    Looking forward to seeing you!
    Hadasit team

  • 5 Apr. 2022 / 3:00 pm
    Biohouse, Hadassah Ein kerem

    Hadasit spring seminar “Algorithms and AI Tools as Commercial Assets in the Biomedical Domain” 5.04.22

    Hadasit spring seminar: Hands-on aspects of AI and Algorithm protection in the Biomedical Domain.
    Topics that were discussed include:

    • The potential of AI tools developed during research to become a commercial asset
    • Patents vs. Know-how
    • Case study from Hadassah research group using AI and algorithms
    • Real-world experience from digital health companies building an IP strategy in the algorithm field
    • Investors’ view on the IP protection of the AI technologies and its influence on the R&D efforts of the researchers and startups


    15:00 – 15:30 – Greg Kirsch, US Patent Attorney, Smith, Gambrell & Russell, USA. “Strategies for protecting with patents computer software and AI inventions in the biomedical sciences: separating the myth from the reality”
    15:30 – 15:45 – Shai Rosenberg, Head of Service for Computational Medicine, Hadassah Medical Center – “Case study on Digital Medicine and Artificial Intelligence for the treatment of cancer patients”
    15:45 – 16:15 – Two case studies by digital health companies on AI protection strategy:
    Erez Naaman, CTO and Co-founde at Scopio Labs.
    Dror Zur, CEO at Magentiq Eye LTD.
    16:15 – 16:30 – Edith Sokol, Founding Partner Patent Attorney at Cohn De Vries Stadler and Co. “Value of IP in algorithm-based technologies – the VC perspective”.

    Click here to view the recording from the event:

  • 21 Dec. 2021 / 2:00 pm
    Hadassah Ein Kerem, Pahama Hall

    Hadasit conference: “Exploring the Challenges of Preclinical Studies. Academic/Clinical/Industry collaborations”

    Professional conference of Hadasit, the Technology Transfer Company of Hadassah Hospitals, in collaboration with the Jerusalem Development Authority (JDA) at Hadassah Ein Kerem campus.
    Join us to hear representatives of commercial, academic, and clinical sectors discussing the challenges faced by medical companies and researchers during their early R&D.

    FOR WEBSITE by maria zavin
    Free registration link:

  • 24 Mar. 2021 / 1:00 pm
    Zoom Meeting

    Hadasit Webinar: Health Tech Wish List – Data, Needs & Funding

    Greetings by Hadassah Medical Organization Leaders Prof Eyal Mishani , Director  of Research and Development DivisionProf Arie Ben Yehuda, Head of Innovation and Division of Medicine 

    HaYaData – Unlocking the Potential of Hadassah data ,Olga Litinetsky Slutsky, Head of HaYaData, Hadassah Data Research Unit

    Hadassah Medical Organization

    The new AI/Pharma Innovation Lab in Israel – building a world-class innovation ecosystemDr. Christian Tidona, Founder and Owner of the BioMed X Institute in Heidelberg

    Mati Gill, Leading the establishment of the new AI/Pharma Innovation Lab in Israel and Head of Teva US Public Policy


  • 15 Sep. 2020 / 5:00 pm
    Zoom Meeting

    Hadasit AI Webinar – Innovators in digital health – time for some hard learned lessons!

    Hadasit, Hadassah data research unit and Hadassah Accelerator gathered amazing group of industry leaders to share their experience, answering one major question: Can AI work in Healthcare?

    • David Gruen will share lessons learned from IBM Watson’s journey
    • Elad Wallach will provide insight into acceptance of AIDOC’s AI in radiology
    • Moran Snir’s Clear Genetics made a light speed 3 year journey from idea to Exit
    • Boaz Buchandler will speak about POMICELL’s approach and cjallenges in AI prediction models for treatment success

    Join us to hear from these experts, and also learn of Hadassah’s new data research unit, and new Hadassah Accelerator class opening soon.

    Join Zoom:



  • 16 Jul. 2020 /
    BioHouse, Hadassah Ein Karem, Jerusalem

    Hadassah Accelerator’s Class #3 is open for applications!

    Hadassah Accelerator, powered by IBM Alpha Zone is a 6-month acceleration program, bringing together Hadassah`s experts, IBM specialists and great digital health companies.
    And from Class 3, the selected companies will also get traction and direct exposure to our new strategic investment partner – Consensus Business Group (CBG).
    Some numbers of our track record:
    Our 11 graduates in the first 2 classes have already raised approximately $10M in investment and grants since the program started.
    8 are continuing to work with Hadassah post program.
    The start-ups technologies cover broad clinical applications:
    – Algorithms for sound analysis, image processing, real-time surgery navigation
    – Wearables for pain-sensing and post-stroke rehabilitation
    – Big data AI for adjustment of multi-drug treatment drug distribution
    If you are developing a great solution in the space of Digital Health and Medical device, this is your chance to join us!
    For more information and registration:


  • 29 Jun. 2020 / 1:00 pm
    Zoom Meeting

    Hadassah Accelerator Demo Day Class 2

    Excited to share we are wrapping up class #2 of Hadassah accelerator powered by Ibmalphazone
    Our demo day tomorrow 29/6 will provide a peak to the companies and will showcase our new strategic investor partner.
    Class #1 graduates raised substantial funding in investment and grants, and we’re hoping to continue the trend.



  • 24 Oct. 2019 / 11:00 am
    Panama Hall, Hadassah Ein Kerem, Jerusalem

    Opening ceremony of the new Wohl Institute For Transnational Medicine

    We are kindly invite you to the opening ceremony

    of the new  Wohl Institute For Transnational Medicine

    at Panama Hall, Hadassah Ein-Kerem, Jerusalem

    INVITATION The Wohl Institute for Translational Medicine


  • 15 Oct. 2018 / 5:30 pm
    Biohouse (Ein Carem Campus)

    From Molecule to Drug


    • Dr. Shai Melcer – Opening words.
    • Dr. Sylvia Kachalsky and Dr. Tamar Raz – Introduction to Recipharm Israel and Hadasit partnership.
    • Dr. Tamar Raz – Selection of indication and its importance in drug development.
    • Dr. Helen Domeshek – Innovation in Bioanalysis: dry blood spot method.
    • Dr. Rephael Nudelman – Impurity qualification and drug development process.


  • 30 May. 2018 / 4:00 pm
    Tourism Auditorium Hadassah Ein-Karem

    From B2B: From Bench to Billions


    16:00-17:00  – Welcome Reception
    Food & Wine

    17:00-17:15 – Greetings
    Prof. Zeev Rotstein, Director General, Hadassah Medical Organization
    Dr. Tamar Raz, CEO, Hadasit Ltd.

    Dr. Noga Yerushalmi, Head of Israel Bio-incubator, HealthCare Fund, M.Ventures – “M. Ventures – Beyond Imagination”

    Keynote Speaker – Dr. Sol Barer
    Founder and Former Chairman and CEO of Celgene (NASDAQ:CELG), and Chairman of the Board, TEVA. – “Building a Biotechnology Company: Lessons from Celgene”